Extracorporeal Membrane Oxygenation Complication Clinical Trial
Official title:
PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS
Extracorporeal life support (ECLS) is used as a last resort intervention in patients with severe cardiac, circulatory and/or respiratory failure with high (>80%) expected mortality. Despite considerable improvements in patient selection and outcomes, mortality and morbidity after ECLS remain high. An improved selection and management of patients who are supported with ECLS is therefore unquestionably needed from a perspective of optimal patient care and the socio-economic impact of this costly intervention.
This observational multicenter study was designed to serve the following objectives: 1. Develop a (dynamic) prediction tool for survival and quality of life outcomes 1 year after ECLS support for the situation at baseline and 7 days after ECLS initiation 2. Study the association between application of left ventricular unloading and ECLS support duration and weanability 3. Description of the incidence of VA ECLS weaning failure and identification of predictors for VA ECLS weaning failure Under this umbrella research protocol, the data collected by this observational multicenter study can also be reused for potential novel substudies with the objective to improve the quality of care and the efficiency of current treatment strategies involving ECLS. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05486559 -
The ECMO-Free Trial
|
N/A | |
| Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
| Not yet recruiting |
NCT05306392 -
Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation
|
N/A | |
| Terminated |
NCT02280460 -
ECMO: Optimization of Its Use
|
||
| Completed |
NCT02271126 -
TEG Anticoagulation Monitoring During ECMO
|
Phase 1 | |
| Completed |
NCT03659513 -
The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy
|
||
| Not yet recruiting |
NCT06338345 -
Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients
|
N/A | |
| Completed |
NCT05948332 -
Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation
|
||
| Recruiting |
NCT04273607 -
Anticoagulation-free VV ECMO for Acute Respiratory Failure
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04956497 -
Registry Study of Extracorporeal Cardiopulmonary Resuscitation (eCPR) in China
|
||
| Completed |
NCT04052230 -
Evolution of Diaphragm Thickness Under Veno-arterial ECMO
|
||
| Terminated |
NCT04524585 -
Partial Neuromuscular Blockade in Acute Respiratory Distress Syndrome
|
N/A | |
| Completed |
NCT04620005 -
Impact of Extra Corporal Membrane Oxygenation Services on Burnout Development in Intensive Care Units.
|
||
| Recruiting |
NCT05721105 -
Evaluation of Long-term Quality of Life in Children Supported With ExtraCorporeal Membrane Oxygenation (ECMO)
|
||
| Recruiting |
NCT06095518 -
DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
|
||
| Recruiting |
NCT03965208 -
Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
|
Phase 4 | |
| Not yet recruiting |
NCT05814094 -
Red Blood Cell Transfusion in ECMO - A Feasibility Trial
|
N/A | |
| Not yet recruiting |
NCT06319677 -
PK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Treatment
|
||
| Completed |
NCT05338593 -
Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.
|
||
| Recruiting |
NCT05730881 -
Comparison of Four Intensive Care Scores in Prediction of VA-ECMO Survival.
|